FIRST USE OF NAFAZATROM, A NEW ANTITHROMBOTIC DRUG, IN PREGNANCY
- 16 June 1984
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 323 (8390) , 1350
- https://doi.org/10.1016/s0140-6736(84)91838-5
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- ANTICARDIOLIPIN ANTIBODIES: DETECTION BY RADIOIMMUNOASSAY AND ASSOCIATION WITH THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUSThe Lancet, 1983
- FETAL SURVIVAL AFTER PREDNISONE SUPPRESSION OF MATERNAL LUPUS-ANTICOAGULANTThe Lancet, 1983
- Decreased prostacyclin production by placental cells in culture from pregnancies complicated by fetal growth retardationBJOG: An International Journal of Obstetrics and Gynaecology, 1983
- Prostacyclin production during pregnancy: Comparison of production during normal pregnancy and pregnancy complicated by hypertensionAmerican Journal of Obstetrics and Gynecology, 1982
- ARTERIAL THROMBOSIS, INTRAUTERINE DEATH AND "LUPUS" ANTICOAGULANT: DETECTION OF IMMUNOGLOBULIN INTERFERING WITH PROSTACYCLIN FORMATIONThe Lancet, 1981
- STIMULATION OF PROSTACYCLIN RELEASE FROM VESSEL WALL BY BAY g 6575, AN ANTITHROMBOTIC COMPOUNDThe Lancet, 1979
- THE ULTRASTRUCTURE OF THE ARTERIAL SUPPLY OF THE HUMAN PLACENTA IN PREGNANCY COMPLICATED BY FETAL GROWTH RETARDATIONBJOG: An International Journal of Obstetrics and Gynaecology, 1976